Source: Atherosclerosis. Unidade: FM
Subjects: OLIGONUCLEOTÍDEOS, HIPERCOLESTEROLEMIA, ANTICORPOS MONOCLONAIS
ABNT
VAHDAT-LASEMI, Fatemeh et al. Angiopoietin-like protein inhibitors: promising agents for the treatment of familial hypercholesterolemia and atherogenic dyslipidemia. Atherosclerosis, v. 405, 2025Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/88266. Acesso em: 24 abr. 2026.APA
Vahdat-lasemi, F., Farhoudi, L., Hosseinikhah, S. M., Santos Filho, R. D. dos, & Sahebkar, A. (2025). Angiopoietin-like protein inhibitors: promising agents for the treatment of familial hypercholesterolemia and atherogenic dyslipidemia. Atherosclerosis, 405. doi:10.1016/j.atherosclerosis.2025.119235NLM
Vahdat-lasemi F, Farhoudi L, Hosseinikhah SM, Santos Filho RD dos, Sahebkar A. Angiopoietin-like protein inhibitors: promising agents for the treatment of familial hypercholesterolemia and atherogenic dyslipidemia [Internet]. Atherosclerosis. 2025 ; 405[citado 2026 abr. 24 ] Available from: https://observatorio.fm.usp.br/handle/OPI/88266Vancouver
Vahdat-lasemi F, Farhoudi L, Hosseinikhah SM, Santos Filho RD dos, Sahebkar A. Angiopoietin-like protein inhibitors: promising agents for the treatment of familial hypercholesterolemia and atherogenic dyslipidemia [Internet]. Atherosclerosis. 2025 ; 405[citado 2026 abr. 24 ] Available from: https://observatorio.fm.usp.br/handle/OPI/88266
